What is AeroSafe Global?
AeroSafe Global positions itself as the leader in biopharmaceutical cold chain solutions, delivering a 'Cold Chain as a Service' (CCaaS) model designed for the secure, sustainable, and effective use of pharmaceuticals. Their integrated service offering encompasses advanced reusable thermal packaging, outsourced supply chain management, and a sophisticated temperature monitoring control tower. This pay-per-turn program not only guarantees reliability but also offers substantial sustainability advantages. Through its industry-leading reuse program, AeroSafe Global significantly reduces carbon emissions by 65% and landfill waste by 90% compared to conventional Styrofoam containers, aligning with growing environmental, social, and governance (ESG) imperatives in the pharmaceutical logistics sector.
How much funding has AeroSafe Global raised?
AeroSafe Global has raised a total of $124.2M across 9 funding rounds:
Private Equity
$4.7M
Private Equity
$2.5M
Private Equity
$5.1M
Private Equity
$10.4M
Private Equity
$1.3M
Private Equity
$1.8M
Other Financing Round
$47.5M
Other Financing Round
$43M
Private Equity (2013): $4.7M, investors not publicly disclosed
Private Equity (2014): $2.5M supported by Mount Royal Ventures and WAVE Equity Partners
Private Equity (2015): $5.1M, investors not publicly disclosed
Private Equity (2015): $10.4M, investors not publicly disclosed
Private Equity (2016): $1.3M, investors not publicly disclosed
Private Equity (2017): $1.8M, investors not publicly disclosed
Other Financing Round (2020): $47.5M supported by Escalate Capital, Peloton Equity LLC, Merck Global Health Innovation Fund, WAVE Equity Partners LLC, Flexstone Partners PTE Ltd, and Hamilton Lane Limited
Other Financing Round (2023): $43M featuring Peloton Equity, NewSpring Capital, Hamilton Lane, and Merck Global Health Innovation Fund
Key Investors in AeroSafe Global
Peloton Equity
Peloton Equity is a growth capital investor specializing in the healthcare sector, leveraging over 20 years of experience to partner with lower-middle-market healthcare companies that demonstrate strong leadership and growth potential.
NewSpring Capital
NewSpring partners with companies in dynamic industries to catalyze new growth. Partnering with management teams to help develop their businesses into market leaders, NewSpring identifies opportunities and builds relationships using through it's network of industry leaders.
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund (MGHIF) is a growth investor that partners with innovative digital health and data science companies. The fund focuses on facilitating and optimizing biopharmaceutical operations. Its primary goal is to improve patient care through these partnerships.
What's next for AeroSafe Global?
The recent major strategic investment in AeroSafe Global, following a history of significant capital raises, indicates a strong market validation and a clear trajectory for scaling operations. This backing is expected to fuel further innovation in their CCaaS platform and expand their reach within the global biopharmaceutical supply chain. The company's focus on sustainability, coupled with its robust technological infrastructure, positions it favorably to capitalize on the increasing demand for reliable and eco-conscious cold chain logistics. Future developments will likely involve enhancing their temperature control capabilities and broadening their service offerings to meet the evolving needs of pharmaceutical manufacturers and distributors.
See full AeroSafe Global company page
